Ischemic stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. For patients who visited the Neurology Department of Southern Hospital of Southern Medical University from January 2020 to February 2025: (1) Age >= 18; (2) Patients diagnosed with ischemic stroke in accordance with the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023"; (3) Within 7 days after discharge, receive one of indobufen, aspirin, cilostazol or clopidogrel, or a combination of two of them (as a dual preventive regimen); (4) The patient has been out of contact with the hospital for more than one year. 2. For patients who visited the Neurology Department of Nanfang Hospital of Southern Medical University from March 2025 to December 2025: (1) Age >= 18; (2) Patients diagnosed with ischemic stroke in accordance with the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023"; (3) Within 7 days after discharge, receive one of indobufen, aspirin, cilostazol or clopidogrel, or a combination of two of them (as a dual preventive regimen); (4) With follow-up records for one year after the initial treatment; (5) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Long term use of oral anticoagulants (such as warfarin, dabigatran, rivaroxaban, etc.) has been required at baseline; 2. History of hemorrhagic stroke and active bleeding; 3. Severe liver and kidney dysfunction (such as AST/ALT > 3 times the upper limit of normal value, or estimated glomerular filtration rate eGFR < 30 mL/min/1.73 m^2), end-stage disease, intracranial tumor or intracranial infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Rankin Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glasgow Coma Scale score;state of existence;Essen score;Barthel Index;Medication usage;National Institute of Health stroke scale; | — |
Countries
China
Contacts
Southern Medical University Southern Hospital